1 reply to this topic

[ImmInst]

(KU Leuven) High-grade glioma is the most aggressive form of brain cancer. Despite improvements in surgical procedures, chemotherapy, and radiotherapy, this type of brain tumor is still notoriously hard to treat: less than 10 percent of patients survive beyond five years. Researchers from KU Leuven, Belgium, have now shown that next-generation cell-based immunotherapy may offer new hope in the fight against brain cancer.

View the full article

[jondoeuk]

A Phase III is under way using a DC vaccine https://clinicaltria...rm=dcvax&rank=1 As are other types of vaccines too https://clinicaltrials.gov/ct2/show/NCT02287428?term=neo+antigen&rank=2 https://clinicaltrials.gov/ct2/show/NCT02510950?term=neo+antigen&rank=9